Aftab Blake
SEC CIK 1886986 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | CSO | 2,981 | — | $564.0K | 21 | 2021-10-12 | 2026-01-24 |
Most active insiders at ACET, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | $5.00M | $674.8K |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 10% | $1.60M | — |
| 3 | Aftab Blake | CSO | — | — |
| 4 | Healey Don | CTO | — | — |
| 5 | Harvey Brian Nicholas | CFO | — | — |
| 6 | Schor Chen | Pres, CEO, Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 | 2026-01-24 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $8.44 | -535 | 2,981 | -15% | -$4,515 | |
| 2025-01-28 | 2025-01-24 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $0.92 | -6,270 | 56.2K | -10% | -$5,768 | |
| D | 2024-01-26 | 2024-01-24 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | A - Grant | $0.00 | +19.7K | 62.5K | +46% | $0 |
| D | 2024-01-26 | 2024-01-24 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $2.40 | -3,565 | 42.8K | -8% | -$8,556 |
| 2023-10-16 | 2023-10-12 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $1.35 | -7,933 | 46.4K | -15% | -$10.7K | |
| D | 2023-01-26 | 2023-01-24 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | A - Grant | $0.00 | +26.1K | 54.3K | +93% | $0 |
| 2022-11-15 | 2022-11-10 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | S - Sale | $21.00 | -6,967 | 28.2K | -20% | -$146.3K | |
| 2022-10-21 | 2022-10-19 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | S - Sale | $16.27 | -8,067 | 35.2K | -19% | -$131.3K | |
| D | 2022-10-14 | 2022-10-13 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $15.92 | -7,933 | 43.2K | -16% | -$126.3K |
| D | 2022-10-14 | 2022-10-12 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | M - OptEx | $7.38 | +3,388 | 52.8K | +7% | +$25.0K |
| D | 2022-10-14 | 2022-10-12 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | S - Sale+OE | $15.40 | -1,646 | 51.2K | -3% | -$25.3K |
| 2022-08-08 | 2022-08-04 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $18.25 | -5,533 | 49.4K | -10% | -$101.0K | |
| 2022-08-08 | 2022-08-04 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | A - Grant | $0.00 | +16.0K | 55.0K | +41% | $0 | |
| 2022-08-05 | 2022-08-03 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | S - Sale | $18.00 | -6,968 | 39.0K | -15% | -$125.4K | |
| 2022-08-03 | 2022-08-01 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | S - Sale | $16.64 | -6,968 | 45.9K | -13% | -$115.9K | |
| 2022-07-07 | 2022-07-05 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | S - Sale | $14.50 | -1,363 | 52.9K | -3% | -$19.8K | |
| 2022-02-16 | 2022-02-14 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $14.27 | -5,533 | 52.9K | -9% | -$79.0K | |
| 2022-02-16 | 2022-02-14 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | A - Grant | $0.00 | +16.0K | 58.4K | +38% | $0 | |
| 2022-02-01 | 2022-01-28 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | F - Tax | $11.69 | -5,564 | 42.4K | -12% | -$65.0K | |
| 2022-02-01 | 2022-01-28 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | A - Grant | $0.00 | +16.0K | 48.0K | +50% | $0 | |
| D | 2021-10-13 | 2021-10-12 | ACET | Adicet Bio, Inc. | Aftab Blake | CSO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations